Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation

• Chengjie Lin,
• Ting Li,
• Yan Wang,
• Shihui Lai,
• Yue Huang,
• Zhenyun Guo,
• Xiang Zhang,
• Shangeng Weng

Affiliations

Chengjie Lin

Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University

Ting Li

Department of Oncology, Fujian Provincial Hospital, Provincial Clinical College of Fujian Medical University

Yan Wang

Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University

Shihui Lai

Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University

Yue Huang

Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University

Zhenyun Guo

Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University

Xiang Zhang

Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University

Shangeng Weng

Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University